Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Vir Biotechnology Inc
(NQ:
VIR
)
8.760
-0.090 (-1.02%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vir Biotechnology Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Planet Labs PBC, GameStop And Other Big Stocks Moving Lower In Friday's Pre-Market Session
September 08, 2023
U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
Is Vir Biotechnology Stock a Buy?
August 11, 2023
The biotech is out to prove that it isn't just a "pandemic stock."
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Tuesday
September 05, 2023
On Tuesday morning, 164 companies achieved new lows for the year.
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Microsoft, Snap, Texas Instruments And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
July 26, 2023
U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Snap Inc. (NYSE: SNAP) shares tumbled 18.6% to $10.18 in...
Via
Benzinga
Where Vir Biotechnology Stands With Analysts
July 21, 2023
Via
Benzinga
Crude Oil Edges Higher; American Airlines Raises Profit Outlook
July 20, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling more than 250 points on Thursday. The Dow traded up 0.60% to 35,270.02 while the NASDAQ fell 1.89% to 14,086.02....
Via
Benzinga
Why Vir Biotechnology Stock Is Plunging Today?
July 20, 2023
Vir Biotechnology Inc (NASDAQ: VIR) shares are tumbling after the company released data from the Phase 2 PENINSULA evaluating VIR-2482 to prevent
Via
Benzinga
What 8 Analyst Ratings Have To Say About Vir Biotechnology
April 04, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 20, 2023
During Thursday's session, 40 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 20, 2023
Via
Benzinga
Dow On Track For 9 Straight After Johnson & Johnson Earnings
July 20, 2023
The Dow Jones Industrial Average is looking to extend its win streak, last seen up 250 points as it paces for its ninth consecutive win.
Via
Talk Markets
Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings
July 20, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite declining over 1% on Thursday. The Dow traded up 0.87% to 35,365.00 while the NASDAQ fell 1.11% to 14,198.86. The S&P 500,...
Via
Benzinga
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 20, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.
Via
Benzinga
Why Shares of Vir Biotechnology Are Plunging Thursday
July 20, 2023
The company had disappointing trial news for one of its lead therapies.
Via
The Motley Fool
Nasdaq Down 50 Points; Tesla Earnings Beat Expectations
July 20, 2023
U.S. stocks traded mixed this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.40% to 35,202.41 while the NASDAQ fell 0.35% to...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 20, 2023
Via
Benzinga
Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics
June 26, 2023
As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other...
Via
Benzinga
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
May 19, 2023
An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the
Via
Benzinga
7 Top-Rated Stocks That Will Boost Your Portfolio in 2023
May 10, 2023
For those seeking to rise above the muck in a big way, these top-rated stocks to buy might accomplish just that.
Via
InvestorPlace
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns
May 08, 2023
The World Health Organization ended the global emergency
Via
Benzinga
The 7 Best Bargain Stocks to Buy for May 2023
May 04, 2023
With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly.
Via
InvestorPlace
Why Shares of Keros Therapeutics Jumped This Week
April 21, 2023
The company appointed a new director and an analyst reiterated his position on the stock.
Via
The Motley Fool
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
April 11, 2023
The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a...
Via
Benzinga
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
April 05, 2023
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.
Via
InvestorPlace
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
March 21, 2023
Via
Benzinga
Biotech Stocks And The SVB Collapse — Here's What We Know
March 14, 2023
The collapse of SVB will have a big impact on early-stage, venture-backed companies.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023
March 06, 2023
Via
Benzinga
Vir Biotechnology Gets Price Targets Cuts By Analysts After Q4 Results
March 06, 2023
Vir Biotechnology, Inc. (NASDAQ: VIR) reported worse-than-expected Q4 results. Vir Biotechnology posted a Q4 loss of $0.76 per share, versus market expectations of $0.39 per share. The company’s...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.